FDA Drug Application (075665) for ETODOLAC by TEVA

Back to FDA Applications sponsored by TEVA

Application Number075665
Product Number001
FormTABLET, EXTENDED RELEASE;ORAL
Dosage600MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameETODOLAC
Active IngredientETODOLAC

Active IngredientCount
List of drugs with Active Ingredient ETODOLAC3


Back to FDA Applications sponsored by TEVA